• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Jim Cramer

Jim Cramer: Betting Against Science Is a Mug's Game

The buyers have decided that the researchers and doctors are going to beat the virus, so you better get on board or miss the move.
By JIM CRAMER Aug 05, 2020 | 03:36 PM EDT
Stocks quotes in this article: PFE, JNJ, LLY, MRK, MRNA, REGN, DD, MMM, DIS, M, UNP, NKE, RL, PVH, PPG, EMR, NUE

We all have our lists of stocks that shine a light on where we are going. Taken one by one, they can mislead us. But taken together, they are like high beams that can steer you in any weather and keep you from straying into the wrong lane.

Wednesday, literally every one of my "go" list lit up, and that means something very big could be afoot.

What's my go list? It's the companies that are doing OK, but if the pandemic were over or had run its course, would be putting up year-over-year numbers that could take your breath away. The go list says that, at this time next year, we will have found a way to go back almost to normal. Sure the virus won't vanish. But it will be tamed to the point that it won't be top of mind.

I am going to rip down that list here, so you know what a go pattern in stocks looks like, but the main thing you have to take away, the lead that can't be buried, is that the buyers have decided that science is going to beat the virus, so you better get on board or miss the move.

Now, some will say the move is because we are about to get a deal between Congress and the administration for a new package to help small business and renters and the unemployed that will keep them from going on bread lines or being evicted. I fully expect such a rescue plan and it would be nuts not to. Why help wreck an economy that was really humming before the Covid-19 grim reaper descended upon us. Anything that has anywhere near $600 in extra benefits per week and offers some sort of eviction protection or rent deferrals will help the small business people who are still alive.

But that's not what I am talking about. My "go" list is not about small business. It's about companies that need a vaccine to thrive and these stocks are saying loud and clear, the wait is over, it's going to happen, because our fabulous scientists have now set into motion so many trials and treatments that the beast will be dealt with and a new normal will be upon us.

I always figured this moment would happen. I said at the beginning of this thing that it would be much tougher than the government would realize, but we have so many fantastic science professors and researchers and medical whizzes at our drug companies that it was only a matter of time, so don't bet against them.

I knew it was bullish to say it, but after all the jeremiads I had thrown out there, I figured it was OK to say that our geniuses -- the kids you couldn't understand and were in awe of in high school and then never bumped into in college because you would fail all of the classes they were in -- would, in the end, tame, if not slay, the beast. I mean do you really think that once unleashed and paid for Pfizer (PFE) , Johnson & Johnson (JNJ) , Eli Lilly (LLY) , Merck (MRK) , Moderna (MRNA) , Regeneron (REGN) among so many others wouldn't eventually come up with something?

Of course, by predicting that, I had to open myself up to the usual ridicule, and not just on Twitter. Some very nice young person, Michael Steinberger, wrote in the Money issue of the New York Times that he was skeptical of the rally that started in March and his skepticism only grew when, and, I quote, "My skepticism only grew when I saw Jim Cramer -- yeah, he's still around -- on CNBC saying that bears like me were ''betting against science' and basically selling the country short, a comment that called to mind Otter's 'student court' peroration in 'Animal House.'"

It's funny, looking back, I think that bears like this nice fellah were basically betting against science and selling America short, and would be proven wrong and I think that, unlike me, who is still around, he won't be when my thesis pans out. And, for the record, I was never an Otter fan and am far more like the three guys sitting on the coach in the hilarious Omega pledge scene. Oh, but let's not forget, Jimmy Chill holds no grudges and I hope Mikey gets a Pulitzer for most gratuitous insults, do they still offer that one?

So what on my go list tells me that science is within a few months of starting to win this war against this murderous beast?

Drum roll please: First is Dupont (DD) . Here's a high quality industrial that's linked to housing, autos, electronics, safety, construction, imaging and transportation, nutrition and biosciences. Almost all of these markets have been threatened or stymied by the virus. My charitable trust has been buying it on the theory that science can win out, but it hasn't been until now that I could say the economy bears could be wrong.

Same with 3M (MMM) . J.P. Morgan Securities' Steve Tusa, the best industrial analyst in the world, spoke positively about the stock Wednesday, suggesting that it could be turning a corner. I thought so, too, after that last conference call where CEO Mike Roman talked about July looking much better than June. I like that one, too, right here, right now.

Disney's (DIS) on my go list. I told you Tuesday night that cost controls shocked us and saved the quarter. But Wednesday's run is about the notion that science is going to eventually triumph over both fear and social distancing. Sure, they did better than expected, but you don't get this big a leap, unless the people selling the country's scientists short are capitulating.

When we are about to see a spurt in world commerce, I look to two stocks as beacons: Mastercard (M) and Union Pacific (UNP) . They are the barometers of activity and their stocks wear it on their sleeves. She we got good fintech pin action off of Square's great numbers but Mastercard failed to rally when it reported because there's been such weak cross border traffic, because of the pandemic. The stock says that's ending. Union Pacific is a bellwether for back-to-school and holiday season clothes from Asia going east. The action says the bears betting on Covid-19 to destroy Christmas like it has destroyed everything else might be wrong.

Apparel's a tell. Nike (NKE) putting on points is always a good sign, but the better ones are the come back of Ralph Lauren (RL) , which really wasn't all that bad yesterday, but more important, PVH (PVH) , which has been taken down to the Covid woodshed long enough. PVH is the go list personified.

Finally, there's three more industrials on the list that don't get a lot of attention: PPG Industries (PPG) , Emerson (EMR) and Nucor (NUE) : Coatings, motors and steel to over-generalize and give a nod to their chief products. When you get all three up, especially after so much carping about Emerson's alleged weak quarter, you, again, have to think that the big money is either hedging its recession bets or siding with American science, or both.

Now Covid-19 is a tricky beast, and it has confounded all of those who don't wear masks and don't social distance. To think that we won't have some outright failures from drug tests is fanciful. But when my go list goes green, which it hasn't in ages, it means to me, not that Washington's going to get its act together -- spare me -- but betting against all of those incredibly smart kids at high school, the ones who actually looked forward to taking chemistry, was always a mug's game.

(JNJ, DD and DIS are holdings in Jim Cramer's Action Alerts PLUS member club. Want to be alerted before Jim Cramer buys or sells these stocks? Learn more now.)

 
Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

Jim Cramer's Action Alerts PLUS member club is long JNJ, DD and DIS.

TAGS: Stocks | Pharmaceuticals | Jim Cramer | Coronavirus |

More from Jim Cramer

Jim Cramer: I'll Put My Money With 'Boring but Lucrative' Any Day

Jim Cramer
Sep 29, 2021 1:28 PM EDT

Let's look at that recent downgrade of 'dull' Morgan Stanley and see why exciting is best left for the stadiums and amusement parks -- and not stocks.

Jim Cramer: America's Toughest Job? Finding Workers

Jim Cramer
Sep 28, 2021 12:17 PM EDT

It's the question of our time: Where are the people willing to take on these better paying gigs? Let's see what's going on and what we need to happen.

Jim Cramer: Here's How Analysts Can Be Off By a Wide Margin

Jim Cramer
Sep 24, 2021 12:02 PM EDT

Let's look at the reactions to Nike, Costco and Salesforce to see what happens when they're viewed from a real world perspective.

Jim Cramer: It's Pure Insanity That We Don't Make Chips Here in the U.S.

Jim Cramer
Sep 23, 2021 11:05 AM EDT

While the big guns meet at the White House about the global chip shortage, the president and these companies are approaching this all wrong.

Jim Cramer: Go Ahead, Have a Cow, but I Say Powell and Xi Are Bulls

Jim Cramer
Sep 22, 2021 3:51 PM EDT

We rallied, because China's President Xi and Fed Chair Powell made decisions that they knew would lead to rallies.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 01:44 PM EDT STEPHEN GUILFOYLE

    Stocks Under $10 Portfolio

    We're making a series of trades here.
  • 03:07 PM EDT PAUL PRICE

    Why Is Walmart Down Big Today?

    Besides its poor earnings report Walmart was way...
  • 07:14 PM EDT PAUL PRICE

    A New, Very Scary Movie

  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2022 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login